1. Biblio

Biblio

Found 13 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is A and Author is William H. Bisson  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
T. D. Hubbard, Murray, I. A., Bisson, W. H., Lahoti, T. S., Gowda, K., Amin, S. G., Patterson, A. D., and Perdew, G. H., “Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles”, Scientific reports, vol. 5, 2015.
B. C. Goodale, La Du, J. K., Bisson, W. H., Janszen, D. B., Waters, K. M., and Tanguay, R. L., “AHR2 Mutant Reveals Functional Diversity of Aryl Hydrocarbon Receptors in Zebrafish”, PLoS ONE, vol. 7, no. 1, p. e29346, 2012.
B. C. Goodale, La Du, J. K., Bisson, W. H., Janszen, D. B., Waters, K. M., and Tanguay, R. L., “AHR2 mutant reveals functional diversity of aryl hydrocarbon receptors in zebrafish.”, PLoS One, vol. 7, no. 1, p. e29346, 2012.
H. Nian, Bisson, W. H., Dashwood, W. - M., Pinto, J. T., and Dashwood, R. H., “$\alpha$-Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells”, Carcinogenesis, vol. 30, pp. 1416–1423, 2009.
S. Sengupta, Bisson, W. H., Mathew, L. K., Kolluri, S. K., and Tanguay, R. L., “Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration model.”, Comp Biochem Physiol C Toxicol Pharmacol, vol. 156, no. 2, pp. 121-9, 2012.
S. Sengupta, Bisson, W. H., Mathew, L. K., Kolluri, S., and Tanguay, R. L., “Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration model”, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 156, no. 2, pp. 121 - 129, 2012.
D. C. Koch, Jang, H. S., O'Donnell, E. F., Punj, S., Kopparapu, P. R., Bisson, W. H., Kerkvliet, N. I., and Kolluri, S., “Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1.”, Oncogene, 2015.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S. Kumar, “The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor.”, PLoS One, vol. 5, no. 10, 2010.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., “The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor”, PLoS ONE, vol. 5, no. 10, p. e13128, 2010.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R., and , “The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor”, PLoS One, vol. 5, p. e13128, 2010.
E. F. O'Donnell, Koch, D. C., Bisson, W. H., Jang, H. S., and Kolluri, S., “The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells”, Cell death & disease, vol. 5, p. e1038, 2014.
Z. Hu, Brooks, S. A., Dormoy, V., Hsu, C. - W., Hsu, H. - Y., Lin, L. - T., Massfelder, T., W Rathmell, K., Xia, M., Al-Mulla, F., and Bisson, W. H., “Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis”, Carcinogenesis, vol. 36, pp. S184–S202, 2015.
W. H. Goodson, Lowe, L., Carpenter, D. O., Gilbertson, M., Ali, A. Manaf, Salsamendi, A. Lopez de C., Lasfar, A., Carnero, A., Azqueta, A., Amedei, A., and Bisson, W. H., “Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead”, Carcinogenesis, vol. 36, pp. S254–S296, 2015.